EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyclodextrin-Mediated Enantiomeric Separation of Idelalisib: A Validated Capillary Electrophoresis and NMR Study

Erzsébet Várnagy, Balázs István Urbán, Mátyás Sári, Balázs Volk iD, Gyula Simig iD, Krisztina Németh iD, Milo Malanga, Ida Fejős iD, Szabolcs Béni iD

International Journal of Molecular Sciences · 05.07.2026 · 27 (13) · 6036

DOI: 10.3390/ijms27136036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.07.2026. Verfasst von Erzsébet Várnagy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Cyclodextrins, Purines. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement Bicyclos, European Union’s Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement Bicyclos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idelalisib (IDE) is a marketed chiral anticancer drug administered as the S-enantiomer, requiring sensitive monitoring of the R-enantiomer to ensure enantiomeric purity. However, no dedicated capillary electrophoresis (CE) method has been reported for trace-level quantification of R-IDE. In this study, a cyclodextrin-mediated CE method was developed for reliable detection of the R-enantiomer at the 0.1% level (LOD 2 µg/mL; LOQ 5 µg/mL). Systematic screening identified hydroxypropyl-β-cyclodextrin (HP-β-CD) with an intermediate degree of substitution (DS~6.8) as the optimal chiral selector, providing efficient enantioseparation (Rs up to 4.3). The method was validated according to ICH Q2(R2) guidelines, demonstrating suitable precision, accuracy, and robustness. Complementary NMR studies revealed hindered rotation of the 3-phenyl moiety and elucidated the molecular basis of enantioselectivity. Complexation with β-CD and HP-β-CD produced clear diastereomeric differentiation in both 1H and 19F NMR spectra, while the simplified 19F NMR profiles enabled direct enantiomer discrimination. NOESY and ROESY experiments demonstrated distinct inclusion modes, with HP-β-CD accommodating both the fluorinated aromatic ring and the 3-phenyl moiety. These interactions may account for the superior enantioseparation observed with HP-β-CD of intermediate DS. Our validated CE method addresses the distomer determination while NMR insights provide mechanistic understanding of the chiral recognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclodextrinsPurinesElectrophoresis, CapillaryStereoisomerismMagnetic Resonance Spectroscopy2-Hydroxypropyl-beta-cyclodextrin

Stichwörter der Autor:innen

19F NMR1H-19F HOESY NMR2D ROESY NMRchiral impurity profilingdesign of experimentsdiastereomeric splittinghost-guest complexationhydroxypropyl-β-cyclodextrin chiral selectorselective phosphoinositide 3-kinase delta inhibitorvariable temperature NMR

Substanzen

CyclodextrinsPurines2-Hydroxypropyl-beta-cyclodextrin

Autor:innen und Institutionen

  • Department of Pharmacognosy, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
  • Center for Pharmacology and Drug Research & Development, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
  • Integrative Health and Environmental Analysis Research Laboratory, Department of Analytical Chemistry, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.
  • Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, H-1475 Budapest, Hungary.
  • Chemical Biology Research Group, Institute of Organic Chemistry, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Krt. 2, H-1117 Budapest, Hungary.
  • CarboHyde Ltd., Berlini u. 47-49, H-1045 Budapest, Hungary.

ORCID-Profile: Balázs Volk, Gyula Simig, Krisztina Németh, Ida Fejős, Szabolcs Béni

Förderung

  • European Union's Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement Bicyclos
  • European Union’s Horizon Europe research and innovation program under the Marie Sklodowska-Curie grant agreement Bicyclos

Zitieren

APA

Várnagy, E., Urbán, B. I., Sári, M., Volk, B., Simig, G., Németh, K., Malanga, M., Fejős, I., & Béni, S. (2026). Cyclodextrin-Mediated Enantiomeric Separation of Idelalisib: A Validated Capillary Electrophoresis and NMR Study. International Journal of Molecular Sciences, 27(13), 6036. https://doi.org/10.3390/ijms27136036

Vancouver

Várnagy E, Urbán BI, Sári M, Volk B, Simig G, Németh K, et al. Cyclodextrin-Mediated Enantiomeric Separation of Idelalisib: A Validated Capillary Electrophoresis and NMR Study. International Journal of Molecular Sciences. 2026;27(13):6036. doi:10.3390/ijms27136036

BibTeX
@article{Vrnagy2026,
  author = {Várnagy, Erzsébet and Urbán, Balázs István and Sári, Mátyás and Volk, Balázs and Simig, Gyula and Németh, Krisztina and Malanga, Milo and Fejős, Ida and Béni, Szabolcs},
  title = {Cyclodextrin-Mediated Enantiomeric Separation of Idelalisib: A Validated Capillary Electrophoresis and NMR Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {6036},
  doi = {10.3390/ijms27136036}
}
Kostenlos starten →